Home / Health / Melanoma: White Blood Cells Predict Treatment Success
Melanoma: White Blood Cells Predict Treatment Success
11 Aug
Summary
- White blood cell changes may predict melanoma treatment response.
- B and T cell activation indicates better patient survival rates.
- The study analyzed blood samples from 24 melanoma patients.
Researchers have pinpointed changes in white blood cells that may predict patient responses to melanoma treatment. This discovery, stemming from a study of 24 patients, offers a potential new avenue for determining who will benefit most from immunotherapy.
The study, conducted in the U.K., focused on B cells and T cells, key components of the immune system. Findings indicate that patients whose B and T cells showed renewed activation and expansion early in treatment tended to experience better survival. Conversely, immature or poorly functioning B cells and a weaker pre-treatment anti-cancer response were linked to poorer outcomes.
This research utilized mass cytometry to analyze immune cells from blood samples of melanoma patients and healthy volunteers. The detailed analysis revealed significant differences in immune cell levels between individuals, potentially explaining varied responses to the same treatments. The findings suggest that blood immune profiling could guide melanoma patient surveillance and early intervention.
